Clinical Trial

Determinants of Medication Non-Adherence Among Patients With Chronic Diseases in Egyptian Community Pharmacies

Study acronym: ADHER-EG
Completed
View on ClinicalTrials.gov →
Summary
Medication non-adherence among patients with chronic diseases is a major public health concern and is associated with poor disease control, increased complications, and higher healthcare costs. Community pharmacists play an important role in supporting patients' medication use through counseling and education; however, the determinants of medication non-adherence among patients attending community pharmacies in Egypt are not well characterized. This multicenter, cross-sectional study aims to assess the prevalence of medication non-adherence and identify factors associated with non-adherence among adult Egyptian patients with chronic diseases attending community pharmacy settings. Medication adherence will be evaluated using the Adherence in Chronic Diseases Scale (ACDS), along with sociodemographic, clinical, and medication-related factors. The findings are expected to provide evidence to inform strategies for improving medication adherence and optimizing chronic disease management in community pharmacy practice in Egypt.
Protocol Amendment History 2 changes
critical Trial completed 2026-04-22
minor Completion moved earlier: 2026-06-01 -> 2026-03-01 2026-04-22
Trial Details
NCT Number NCT07375550
Lead Sponsor Egyptian Chinese University
Conditions Chronic Disease
Enrollment 261 participants
Start Date 2026-01-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-21